News
Dr. Reddy’s and OneSource agree not to sell Novo Nordisk’s anti-obesity drug in India amid patent infringement lawsuit.
It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results